[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Pomalidomide Market Research Report Forecast 2017-2021

May 2017 | 101 pages | ID: U04705A6C28EN
S&P Consulting

US$ 2,960.00 US$ 3,700.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States Pomalidomide Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Pomalidomide industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Pomalidomide market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:

Pfizer
GlaxoSmithKline
Sandoz
Celltrion
Delenex Therapeutics
Bionovis
Fujifilm Kyowa Kirin Biologics
AryoGen Biopharma
MedImmune

United States Pomalidomide Market: Product Segment Analysis
  • Type 1
  • Type 2
  • Type 3
United States Pomalidomide Market: Application Segment Analysis
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 POMALIDOMIDE MARKET OVERVIEW

1.1 Product Overview and Scope of Pomalidomide
1.2 Pomalidomide Market Segmentation by Type
  1.2.1 United States Production Market Share of Pomalidomide by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Pomalidomide Market Segmentation by Application
  1.3.1 Pomalidomide Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Pomalidomide (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON POMALIDOMIDE INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES POMALIDOMIDE MARKET COMPETITION BY MANUFACTURERS

3.1 United States Pomalidomide Production and Share by Manufacturers (2015 and 2016)
3.2 United States Pomalidomide Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Pomalidomide Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Pomalidomide Manufacturing Base Distribution, Production Area and Product Type
3.5 Pomalidomide Market Competitive Situation and Trends
  3.5.1 Pomalidomide Market Concentration Rate
  3.5.2 Pomalidomide Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES POMALIDOMIDE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Pomalidomide Production and Market Share by Type (2012-2017)
4.2 United States Pomalidomide Revenue and Market Share by Type (2012-2017)
4.3 United States Pomalidomide Price by Type (2012-2017)
4.4 United States Pomalidomide Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES POMALIDOMIDE MARKET ANALYSIS BY APPLICATION

5.1 United States Pomalidomide Consumption and Market Share by Application (2012-2017)
5.2 United States Pomalidomide Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES POMALIDOMIDE MANUFACTURERS ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 GlaxoSmithKline
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Sandoz
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Celltrion
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Delenex Therapeutics
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Bionovis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Fujifilm Kyowa Kirin Biologics
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 AryoGen Biopharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 MedImmune
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 POMALIDOMIDE MANUFACTURING COST ANALYSIS

7.1 Pomalidomide Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pomalidomide

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pomalidomide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pomalidomide Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES POMALIDOMIDE MARKET FORECAST (2017-2021)

11.1 United States Pomalidomide Production, Revenue Forecast (2017-2021)
11.2 United States Pomalidomide Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Pomalidomide Production Forecast by Type (2017-2021)
11.4 United States Pomalidomide Consumption Forecast by Application (2017-2021)
11.5 Pomalidomide Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Pomalidomide
Table Classification of Pomalidomide
Figure United States Sales Market Share of Pomalidomide by Type in 2015
Table Application of Pomalidomide
Figure United States Sales Market Share of Pomalidomide by Application in 2015
Figure United States Pomalidomide Sales and Growth Rate (2011-2021)
Figure United States Pomalidomide Revenue and Growth Rate (2011-2021)
Table United States Pomalidomide Sales of Key Manufacturers (2015 and 2016)
Table United States Pomalidomide Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pomalidomide Sales Share by Manufacturers
Figure 2016 Pomalidomide Sales Share by Manufacturers
Table United States Pomalidomide Revenue by Manufacturers (2015 and 2016)
Table United States Pomalidomide Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pomalidomide Revenue Share by Manufacturers
Table 2016 United States Pomalidomide Revenue Share by Manufacturers
Table United States Market Pomalidomide Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pomalidomide Average Price of Key Manufacturers in 2015
Figure Pomalidomide Market Share of Top 3 Manufacturers
Figure Pomalidomide Market Share of Top 5 Manufacturers
Table United States Pomalidomide Sales by Type (2012-2017)
Table United States Pomalidomide Sales Share by Type (2012-2017)
Figure United States Pomalidomide Sales Market Share by Type in 2015
Table United States Pomalidomide Revenue and Market Share by Type (2012-2017)
Table United States Pomalidomide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pomalidomide by Type (2012-2017)
Table United States Pomalidomide Price by Type (2012-2017)
Figure United States Pomalidomide Sales Growth Rate by Type (2012-2017)
Table United States Pomalidomide Sales by Application (2012-2017)
Table United States Pomalidomide Sales Market Share by Application (2012-2017)
Figure United States Pomalidomide Sales Market Share by Application in 2015
Table United States Pomalidomide Sales Growth Rate by Application (2012-2017)
Figure United States Pomalidomide Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Pomalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Pomalidomide Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Pomalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Pomalidomide Market Share (2012-2017)
Table Sandoz Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sandoz Pomalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Sandoz Pomalidomide Market Share (2012-2017)
Table Celltrion Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celltrion Pomalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Celltrion Pomalidomide Market Share (2012-2017)
Table Delenex Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Delenex Therapeutics Pomalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Delenex Therapeutics Pomalidomide Market Share (2012-2017)
Table Bionovis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bionovis Pomalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Bionovis Pomalidomide Market Share (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fujifilm Kyowa Kirin Biologics Pomalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Pomalidomide Market Share (2012-2017)
Table AryoGen Biopharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AryoGen Biopharma Pomalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table AryoGen Biopharma Pomalidomide Market Share (2012-2017)
Table MedImmune Basic Information, Manufacturing Base, Production Area and Its Competitors
Table MedImmune Pomalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Pomalidomide Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pomalidomide
Figure Manufacturing Process Analysis of Pomalidomide
Figure Pomalidomide Industrial Chain Analysis
Table Raw Materials Sources of Pomalidomide Major Manufacturers in 2015
Table Major Buyers of Pomalidomide
Table Distributors/Traders List
Figure United States Pomalidomide Production and Growth Rate Forecast (2017-2021)
Figure United States Pomalidomide Revenue and Growth Rate Forecast (2017-2021)
Table United States Pomalidomide Production Forecast by Type (2017-2021)
Table United States Pomalidomide Consumption Forecast by Application (2017-2021)


More Publications